Predicting survival in patients receiving continuous flow left ventricular assist devices: The Heartmate II risk score

Journal of the American College of Cardiology

Volumn 61, Issue 3, 2013, Pages 313-321

  Cowger, Jennifer ^a   Sundareswaran, Kartik ^b   Rogers, Joseph G ^c   Park, Soon J ^d   Pagani, Francis D ^a   Bhat, Geetha ^e   Jaski, Brian ^f   Farrar, David J ^b   Slaughter, Mark S ^g  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b THORATEC CORPORATION   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d MAYO CLINIC   (United States)

^e ADVOCATE CHRIST MEDICAL CENTER   (United States)

^f SHARP MEMORIAL HOSPITAL   (United States)

^g UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

heart failure; left ventricular assist device; mortality; risk

Indexed keywords

ADULT; ARTICLE; BLOOD CLOTTING DISORDER; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; FEMALE; HEARTMATE II RISK SCORE; HUMAN; HYPOALBUMINEMIA; INTERMETHOD COMPARISON; KIDNEY DYSFUNCTION; LEFT VENTRICULAR ASSIST DEVICE; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PRIORITY JOURNAL; RISK ASSESSMENT; SCORING SYSTEM; SURVIVAL RATE; SURVIVAL TIME;

AGED; FEMALE; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT SELECTION; PRODUCT SURVEILLANCE, POSTMARKETING; PROGNOSIS; RISK ASSESSMENT; ROC CURVE; SURVIVAL ANALYSIS;

EID: 84872283890     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.09.055     Document Type: Article

References (21)

1. J.K. Kirklin, D.C. Naftel, R.L. Kormos The Fourth INTERMACS Annual Report: 4,000 implants and counting J Heart Lung Transplant 31 2012 117 126
2. K. Lietz, J.W. Long, A.G. Kfoury Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era Implications for patient selection Circulation 116 2007 497 505
3. J.C. Matthews, F.D. Pagani, J.W. Haft, T.M. Koelling, D.C. Naftel, K.D. Aaronson Model for end-stage liver disease score predicts left ventricular assist device operative transfusion requirements, morbidity, and mortality Circulation 121 2010 214 220
4. M.C. Oz, D.J. Goldstein, P. Pepino Screening scale predicts patients successfully receiving long-term implantable left ventricular assist devices Circulation 92 1995 II169 II173
5. E.A. Rose, A.C. Gelijns, A.J. Moskowitz Long-term mechanical left ventricular assistance for end-stage heart failure N Engl J Med 345 2001 1435 1443
6. R.C. Starling, Y. Naka, A.J. Boyle Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support) J Am Coll Cardiol 57 2011 1890 1898
7. S.J. Park, C.A. Milano, A.J. Tatooles Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy Circ Heart Fail 5 2012 241 248
8. J.J. Teuteberg, G.A. Ewald, R.M. Adamson Risk assessment for continuous flow left ventricular assist devices: does the destination therapy risk score work?: an analysis of over 1,000 patients J Am Coll Cardiol 60 2012 44 51
9. L.W. Miller, F.D. Pagani, S.D. Russell Use of a continuous-flow device in patients awaiting heart transplantation N Engl J Med 357 2007 885 896
10. F.D. Pagani, L.W. Miller, S.D. Russell Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device J Am Coll Cardiol 54 2009 312 321
11. M.S. Slaughter, J.G. Rogers, C.A. Milano Advanced heart failure treated with continuous-flow left ventricular assist device N Engl J Med 361 2009 2241 2251
12. V. Rao, M.C. Oz, M.A. Flannery, K.A. Catanese, M. Argenziano, Y. Naka Revised screening scale to predict survival after insertion of a left ventricular assist device J Thorac Cardiovasc Surg 125 2003 855 862
13. K. Lietz, J.W. Long, A.G. Kfoury Impact of center volume on outcomes of left ventricular assist device implantation as destination therapy: analysis of the Thoratec HeartMate Registry, 1998 to 2005 Circ Heart Fail 2 2009 3 10
14. E.R. DeLong, D.M. DeLong, D.L. Clarke-Pearson Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach Biometrics 44 1988 837 845
15. J.M. Schaffer, J.G. Allen, E.S. Weiss Evaluation of risk indices in continuous-flow left ventricular assist device patients Ann Thorac Surg 88 2009 1889 1896
16. A.J. Boyle, D.D. Ascheim, M.J. Russo Clinical outcomes for continuous-flow left ventricular assist device patients stratified by pre-operative INTERMACS classification J Heart Lung Transplant 30 2011 402 407
17. L.W. Stevenson, F.D. Pagani, J.B. Young INTERMACS profiles of advanced heart failure: the current picture J Heart Lung Transplant 28 2009 535 541
18. J.K. Kirklin, D.C. Naftel, L.W. Stevenson INTERMACS database for durable devices for circulatory support: first annual report J Heart Lung Transplant 27 2008 1065 1072
19. J.A. Yang, T.S. Kato, B.P. Shulman Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support: use of the Model of End-stage Liver Disease (MELD) and MELD eXcluding INR (MELD-XI) scoring system J Heart Lung Transplant 31 2012 601 610
20. M.J. Barry, S. Edgman-Levitan Shared decision making - pinnacle of patient-centered care N Engl J Med 366 2012 780 781
21. L.A. Allen, J.E. Yager, M.J. Funk Discordance between patient-predicted and model-predicted life expectancy among ambulatory patients with heart failure JAMA 299 2008 2533 2542